Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Erik S, Pena"'
Autor:
Dylan A. Hendy, Erik S. Pena, Luis Ontiveros‐Padilla, Timothy A. Dixon, Denzel D. Middleton, Grace L. Williamson, Nicole Rose Lukesh, Sean R. Simpson, Rebeca T. Stiepel, Md Jahirul Islam, Michael A. Carlock, Ted M. Ross, Eric M. Bachelder, Kristy M. Ainslie
Publikováno v:
Bioengineering & Translational Medicine, Vol 9, Iss 2, Pp n/a-n/a (2024)
Abstract Influenza virus outbreaks are a major burden worldwide each year. Current vaccination strategies are inadequate due to antigenic drift/shift of the virus and the elicitation of low immune responses. The use of computationally optimized broad
Externí odkaz:
https://doaj.org/article/e45d7ae58a0e451d9e71585438cf9fcd
Autor:
Luis Ontiveros-Padilla, Cole J. Batty, Dylan A. Hendy, Erik S. Pena, John A. Roque, Rebeca T. Stiepel, Michael A. Carlock, Sean R. Simpson, Ted M. Ross, Soman N. Abraham, Herman F. Staats, Eric M. Bachelder, Kristy M. Ainslie
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Currently licensed vaccine adjuvants offer limited mucosal immunity, which is needed to better combat respiratory infections such as influenza. Mast cells (MCs) are emerging as a target for a new class of mucosal vaccine adjuvants. Here, we developed
Externí odkaz:
https://doaj.org/article/e70567c612c44f1da172b79c933b2fc4
Autor:
Rebeca T, Stiepel, Erik S, Pena, Stephen A, Ehrenzeller, Matthew D, Gallovic, Liubov M, Lifshits, Christopher J, Genito, Eric M, Bachelder, Kristy M, Ainslie
Publikováno v:
Journal of Controlled Release. 351:883-895
Effective drug delivery requires ample dosing at the target tissue while minimizing negative side effects. Drug delivery vehicles such as polymeric nanoparticles (NPs) are often employed to accomplish this challenge. In this work, drug release of num
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c83059266f159c8131826791a0864d1
https://doi.org/10.1016/j.jconrel.2022.09.067
https://doi.org/10.1016/j.jconrel.2022.09.067
Autor:
Matthew D. Gallovic, Robert D. Junkins, Adam M. Sandor, Erik S. Pena, Christopher J. Sample, Ariel K. Mason, Leslee C. Arwood, Rebecca A. Sahm, Eric M. Bachelder, Kristy M. Ainslie, Gregory D. Sempowski, Jenny P.-Y. Ting
Publikováno v:
J Control Release
The COVID-19 pandemic highlights the need for effective vaccines against respiratory viruses. An ideal vaccine should induce robust and long-lasting responses with high manufacturing scalability. We used an adjuvant comprised of a Stimulator of Inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20087447a615e18aec17eddcf52b2b7a
https://doi.org/10.1016/j.jconrel.2022.05.017
https://doi.org/10.1016/j.jconrel.2022.05.017
Autor:
Devika M. Varma, Cole J. Batty, Rebeca T. Stiepel, Elizabeth G. Graham-Gurysh, John A. Roque, Erik S. Pena, M. Shamim Hasan Zahid, Kunyu Qiu, Aaron Anselmo, David B. Hill, Ted M. Ross, Eric M. Bachelder, Kristy M. Ainslie
Publikováno v:
ACS Biomater Sci Eng
Influenza virus is a major cause of death on a global scale. Seasonal vaccines have been developed to combat influenza; however, they are not always highly effective. One strategy to develop a more broadly active influenza vaccine is the use of multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef161f7569b8c078844c12a896501cbf
https://doi.org/10.1021/acsbiomaterials.2c00015
https://doi.org/10.1021/acsbiomaterials.2c00015
Autor:
Erik S. Pena, Liubov M. Lifshits, Meital Eckshtain‐Levi, Eric M. Bachelder, Kristy M. Ainslie
Publikováno v:
WIREs Nanomedicine and Nanobiotechnology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6a1c84157dc40d840f5db5be557a834
https://doi.org/10.1002/wnan.1877
https://doi.org/10.1002/wnan.1877
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13160, p 13160 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Glioblastoma multiforme (GBM) is the most common form of primary brain cancer and has the highest morbidity rate and current treatments result in a bleak 5-year survival rate of 5.6%. Interstitial therapy is one option to increase survival. Drug deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1f3e6e223790b71cc7bce70830805c
https://www.mdpi.com/1422-0067/22/23/13160
https://www.mdpi.com/1422-0067/22/23/13160
Autor:
Hendy, Dylan A.1, Pena, Erik S.2, Ontiveros-Padilla, Luis1, Dixon, Timothy A.1, Middleton, Denzel D.1, Williamson, Grace L.1, Lukesh, Nicole Rose1, Simpson, Sean R.1, Stiepel, Rebeca T.1, Islam, Md Jahirul1, Carlock, Michael A.3, Ross, Ted M.3,4,5, Bachelder, Eric M.1, Ainslie, Kristy M.1,2,6 ainsliek@email.unc.edu
Publikováno v:
Bioengineering & Translational Medicine. Mar2024, Vol. 9 Issue 2, p1-16. 16p.
Autor:
Pena, Erik S., Lifshits, Liubov M., Eckshtain‐Levi, Meital, Bachelder, Eric M., Ainslie, Kristy M.
Publikováno v:
WIREs: Nanomedicine & Nanobiotechnology; Jul2023, Vol. 15 Issue 4, p1-24, 24p